Morcelamento elétrico de tecido uterino: qual o risco potencial de disseminação de neoplasias malignas?

Abstract

The US Food and Drug Administration (FDA) released a safety communication advising the potential risk of inadvertent spread of cancer cellsafter the use of electrical morcellator in minimally invasive procedures. This article aims to evaluate the scientific evidence regarding the risk of spread of cancer after uterine morcellation, the incidence of uterine sarcoma among women diagnosed with benign uterine disease, the possibility of preoperative assessment of this risk, the main medical societies positions statements regarding theuse of electric morcellation and the FDA recommendation’s impact on clinical practice. A review of the literature and a research of the main medical societies positions statements regarding the use of electric morcellation in minimally invasive surgeries were done.